Educational content, not medical advice. This article explains published biochemistry around the MTRR gene for general education. It is not a diagnosis, treatment, or prevention claim, and genotype is never destiny. Talk to a licensed clinician or genetic counselor before making any health decision or changing supplements.
If you've mapped your methylation genes, you've probably seen MTHFR steal the spotlight. But the methylation cycle can't turn without a second, quieter enzyme keeping vitamin B12 in working order: MTRR. Its most-discussed variant, A66G (rs1801394), is a common polymorphism that shows up on nearly every biohacker's methylation panel — and it's a useful lens for understanding why "just take B12" isn't always the whole story.
Key Takeaway
The MTRR gene codes for methionine synthase reductase, the enzyme that regenerates the active form of vitamin B12 used by methionine synthase (MTR). Every time MTR converts homocysteine back into methionine — a core step of the methylation cycle — its B12 cofactor gets oxidized and briefly deactivated. MTRR's job is to "recharge" that B12 so the cycle can keep running. The common A66G variant (rs1801394), an A-to-G change that swaps isoleucine for methionine at position 22, is associated in some studies with modestly reduced enzyme efficiency, meaning B12 may be reactivated a little less readily. In the biohacking community this is one reason methyl-B12 (methylcobalamin) and adequate B12 status get emphasized for people carrying MTRR variants — the logic being that keeping B12 well-supplied supports the recycling step. Evidence for the variant's real-world impact is modest and mixed, so it's a consideration to discuss with a clinician, not a mandate to supplement.
What Does the MTRR Gene Do?
The MTRR gene encodes methionine synthase reductase. To understand its role, you first have to know what it's supporting.
At the center of the methylation cycle sits an enzyme called methionine synthase (MTR). MTR performs a critical hand-off: it takes a methyl group from methylfolate and uses vitamin B12 (as methylcobalamin) as the middle-man to transfer that methyl group onto homocysteine, regenerating methionine. Methionine then becomes SAMe, the universal methyl donor your body uses for hundreds of methylation reactions.
There's a catch. Each time MTR runs this reaction, its cobalamin (B12) cofactor occasionally gets oxidized into an inactive state. When that happens, MTR stalls — it can't run again until its B12 is restored. That's where MTRR comes in. Methionine synthase reductase reduces the oxidized cobalamin back to its active form, effectively recharging the B12 so MTR can keep cycling.
So MTRR doesn't touch homocysteine directly. It's the maintenance crew that keeps the B12-dependent engine of methylation from seizing up.
What Is the MTRR A66G Variant?
A66G — formally rs1801394 — is the most common and most studied MTRR polymorphism. The name encodes the change: an adenine (A) is swapped for a guanine (G) at nucleotide position 66, which changes the amino acid at position 22 from isoleucine to methionine (an I22M substitution).
Like most methylation SNPs, it comes in three genotypes:
- AA — the common ("wild-type") version, associated with typical enzyme activity.
- AG — heterozygous, one copy of the variant.
- GG — homozygous for the variant, which is the version most often flagged in methylation reports.
Some studies associate the G allele with modestly reduced MTRR efficiency at reactivating B12. The keyword is modest — this is a common variant found across the general population, not a rare mutation, and its measured effects are subtle and inconsistent between studies.
Does MTRR A66G Affect B12 Status?
This is the practical question, and the honest answer is maybe, a little, in some people.
The mechanistic logic is clean: if MTRR reactivates B12 slightly less efficiently, then MTR might stall a bit more often, which could nudge homocysteine upward and put a premium on having plenty of B12 available. Some research has linked MTRR A66G — particularly in combination with low B12 status or with MTHFR variants — to higher homocysteine and other outcomes.
But the effect sizes are small, and MTRR rarely acts alone. Its impact appears to depend heavily on B12 sufficiency: when B12 is abundant, a slightly less efficient recycling enzyme matters less, because there's plenty of substrate to work with. When B12 is low, the recycling bottleneck may become more noticeable. This gene-nutrient interaction is why B12 status, rather than the SNP in isolation, tends to be the more actionable piece.
Why Do Biohackers Emphasize Methyl-B12 for MTRR?
Walk through any methylation forum and you'll see methylcobalamin (methyl-B12) recommended for people with MTRR variants. The reasoning goes like this: since MTRR exists to keep B12 in its active methyl-form for MTR, keeping the body well-supplied with the already-methylated form of B12 supposedly reduces the burden on the recycling step.
It's an intuitive story, and methyl-B12 is a legitimate, bioavailable form of the vitamin. A few caveats keep it honest:
- The form debate is unsettled. Whether methylcobalamin is meaningfully superior to hydroxocobalamin or other forms for MTRR carriers is not firmly established. Some people actually tolerate hydroxocobalamin better, especially if they're sensitive to methyl donors.
- More is not automatically better. Piling on methylated B-vitamins can trigger overmethylation-type symptoms in sensitive individuals, particularly those who also carry slow COMT variants.
- Status beats genotype. Testing actual B12 (and homocysteine) levels tells you far more than a SNP alone about whether B12 is a real issue for you.
For a fuller breakdown of the different B12 and B-vitamin forms, see our guide to methylated B vitamins — benefits, forms, and side effects.
How Does MTRR Fit Into the Bigger Methylation Picture?
MTRR is best understood as one node in a connected circuit, not a standalone dial. It supports MTR, which depends on methylfolate produced by MTHFR, and it works alongside genes that feed and drain the same homocysteine pool.
That interconnection is why methylation is best read across genes rather than one SNP at a time:
- MTHFR produces the methylfolate that MTR uses — so a sluggish MTHFR plus a less-efficient MTRR compounds the pressure on the remethylation step. See methylfolate and L-methylfolate forms for MTHFR.
- CBS drains homocysteine out of the cycle toward transsulfuration, the opposite direction from MTR's remethylation. See CBS gene mutation and methylation, explained.
- Overmethylation risk rises when methyl donors (methylfolate, methyl-B12) are pushed hard in sensitive people. See overmethylation symptoms, causes, slow COMT, and MTHFR.
Want to see your own MTRR A66G result rather than assume the worst? Ask your own DNA lets you look up your MTRR (rs1801394) genotype directly and bring specific, informed questions to a clinician — instead of adopting a one-size-fits-all B12 protocol.
FAQ
What does the MTRR gene do? The MTRR gene codes for methionine synthase reductase, the enzyme that regenerates the active form of vitamin B12 used by methionine synthase (MTR). Without MTRR recharging that B12, the remethylation step of the methylation cycle would repeatedly stall.
What is the MTRR A66G variant? A66G (rs1801394) is a common MTRR polymorphism where an A is swapped for a G at position 66, changing isoleucine to methionine at amino acid 22. The GG genotype is the version most often flagged on methylation panels and is associated in some studies with modestly reduced enzyme efficiency.
Does MTRR A66G mean I'm deficient in B12? No. The variant may modestly affect how efficiently B12 is recycled, and its impact appears to depend on your actual B12 status, but it does not by itself indicate a deficiency. Only testing your B12 (and homocysteine) levels can tell you that.
Should I take methyl-B12 if I have an MTRR variant? Methylcobalamin is a legitimate, bioavailable form of B12 that biohackers often favor for MTRR variants, but whether it's right for you — versus hydroxocobalamin or another form — is an individual question. Some methyl-sensitive people tolerate non-methylated forms better. Discuss it with a clinician.
Does MTRR A66G interact with MTHFR? Yes, functionally. MTRR supports the same remethylation step that depends on the methylfolate MTHFR produces. A less-efficient MTHFR combined with a less-efficient MTRR can add pressure to homocysteine remethylation, which is why the two are often looked at together.
Can I check my own MTRR genotype? Yes — if you already have raw genetic data, you can look up your MTRR (rs1801394) result and explore what it means with a tool like Ask My DNA, then bring the findings to a clinician for personalized guidance.
Reminder: Genetic variants describe tendencies in biochemical pathways, not fixed outcomes. Nothing in this article diagnoses, treats, prevents, or cures any condition. Always consult a qualified healthcare provider before changing supplements, medications, or health decisions based on genetic information.